Literature DB >> 16227801

The effect of highly active antiretroviral treatment on viral load and antiretroviral drug levels in breast milk.

Robert Colebunders1, Beata Hodossy, David Burger, Tania Daems, Kristien Roelens, Marc Coppens, Ben Van Bulck, Yves Jacquemyn, Eric Van Wijngaerden, Katrien Fransen.   

Abstract

Viral load and drug levels were measured in the plasma and breast milk of nine mothers treated with highly active antiretroviral therapy (HAART) and one woman treated only with zidovudine during delivery. In all HAART-treated women after delivery the viral load was less than 400 copies/ml in plasma and breast milk. Compared with the plasma concentration, the breast milk concentration was between 68 and 90% for nevirapine, 6 and 24% for nelfinavir and 90 and 540% for indinavir.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227801     DOI: 10.1097/01.aids.0000188428.33280.41

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  11 in total

1.  Postpartum plasma CD4 change in HIV-positive women: implications for timing of HAART initiation.

Authors:  Ai Koyanagi; Andrea J Ruff; Lawrence H Moulton; Robert Ntozini; Kuda Mutasa; Peter Iliff; Jean H Humphrey
Journal:  AIDS Res Hum Retroviruses       Date:  2010-05       Impact factor: 2.205

2.  An avoidable transmission of HIV from mother to child.

Authors:  Tyler O'Bryan; Taj Jadavji; John Kim; M John Gill
Journal:  CMAJ       Date:  2010-11-22       Impact factor: 8.262

3.  Stavudine concentrations in women receiving postpartum antiretroviral treatment and their breastfeeding infants.

Authors:  Jessica M Fogel; Taha E Taha; Jin Sun; Donald R Hoover; Teresa L Parsons; Johnstone J Kumwenda; Lynne M Mofenson; Mary Glenn Fowler; Craig W Hendrix; Newton I Kumwenda; Susan H Eshleman; Mark Mirochnick
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-15       Impact factor: 3.731

4.  Extended prophylaxis with nevirapine and cotrimoxazole among HIV-exposed uninfected infants is well tolerated.

Authors:  Jim Aizire; Mary Glenn Fowler; Jing Wang; Avinash K Shetty; Lynda Stranix-Chibanda; Moreen Kamateeka; Elizabeth R Brown; Steve G Bolton; Philippa M Musoke; Hoosen Coovadia
Journal:  AIDS       Date:  2012-01-28       Impact factor: 4.177

5.  Nelfinavir and its active metabolite, hydroxy-t-butylamidenelfinavir (M8), are transferred in small quantities to breast milk and do not reach biologically significant concentrations in breast-feeding infants whose mothers are taking nelfinavir.

Authors:  Paul J Weidle; Clement Zeh; Amy Martin; Richard Lando; Frank Angira; Joseph Osoga; Paul Ogindo; Sonali Girde; Timothy D Minniear; Timothy K Thomas
Journal:  Antimicrob Agents Chemother       Date:  2011-08-29       Impact factor: 5.191

6.  Validation and clinical application of a novel LC-MS method for quantification of dolutegravir in breast milk.

Authors:  Joshua Gini; Sujan Dilly Penchala; Alieu Amara; Elizabeth Challenger; Deirdre Egan; Catriona Waitt; Mohammed Lamorde; Catherine Orrell; Landon Myer; Saye Khoo; Laura J Else
Journal:  Bioanalysis       Date:  2018-11-19       Impact factor: 2.681

Review 7.  Antiretroviral bioanalysis methods of tissues and body biofluids.

Authors:  Robin DiFrancesco; Getrude Maduke; Rutva Patel; Charlene R Taylor; Gene D Morse
Journal:  Bioanalysis       Date:  2013-02       Impact factor: 2.681

8.  Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy.

Authors:  Mark Mirochnick; Timothy Thomas; Edmund Capparelli; Clement Zeh; Diane Holland; Rose Masaba; Prisca Odhiambo; Mary Glenn Fowler; Paul J Weidle; Michael C Thigpen
Journal:  Antimicrob Agents Chemother       Date:  2008-12-29       Impact factor: 5.191

9.  HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis.

Authors:  Clement Zeh; Paul J Weidle; Lillian Nafisa; Humphrey M Lwamba; Jully Okonji; Emily Anyango; Philip Bondo; Rose Masaba; Mary Glenn Fowler; John N Nkengasong; Michael C Thigpen; Timothy Thomas
Journal:  PLoS Med       Date:  2011-03-29       Impact factor: 11.069

10.  Dynamics of the infant gut microbiota in the first 18 months of life: the impact of maternal HIV infection and breastfeeding.

Authors:  Claire M Fraser; Man Charurat; Silvia Grant-Beurmann; Jibreel Jumare; Nicaise Ndembi; Olayemi Matthew; Ashley Shutt; Augustine Omoigberale; Olivia A Martin
Journal:  Microbiome       Date:  2022-04-12       Impact factor: 14.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.